Neulasta
Ailment: Infection from Chemotherapy
U.S. Sales: $3.6 billion
Owner: Amgen
Neulasta strengthens the body’s immune system when it’s been weakened by chemotherapy by boosting the white blood cell count. This spring, Amgen introduced a patch that delivers the drug the day after chemotherapy, eliminating the need for an additional doctor’s visit.
